FC

Falgunsinh Chanubha Rana

Active Director Designated Partner DIN 07719029
DIN 07719029 First appointment Feb 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Falgunsinh Chanubha Rana

Data last updated:

Falgunsinh Chanubha Rana is a Designated Partner at Welzijn Pharmaceuticals Llp (since 2017). The company operates in Business Services.

DIN 07719029
Primary Designation Designated Partner
Industry Business Services
First Appointment 10 Feb 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Feb 20172017Active

Board colleagues of Falgunsinh Chanubha Rana

NameDINCompanyDesignation
Tejaskumar M Shah07720215Welzijn Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Welzijn Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Falgunsinh Chanubha Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Falgunsinh Chanubha Rana

Falgunsinh Chanubha Rana currently holds 1 directorship: Welzijn Pharmaceuticals Llp (Designated Partner, since 10 Feb 2017).

Falgunsinh Chanubha Rana was first appointed on 10 Feb 2017 as Designated Partner at Welzijn Pharmaceuticals Llp.

The current boards of Falgunsinh Chanubha Rana's companies include Tejaskumar M Shah (Welzijn Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available